RedHill Biopharma (RDHL) Return on Capital Employed Growth (1y) (2017 - 2023)
RedHill Biopharma (RDHL) Return on Capital Employed Growth (1y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1,195.00 |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | -679.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 876,690.00 |
| Dec 31, 2022 | 18,799.00 |
| Jun 30, 2022 | -905,954.00 |
| Dec 31, 2021 | -14,214.00 |
| Jun 30, 2021 | 1,523.00 |
| Dec 31, 2020 | -2,997.00 |
| Jun 30, 2020 | -6,085.00 |
| Dec 31, 2019 | 1,001.00 |
| Jun 30, 2019 | -4,471.00 |
| Dec 31, 2018 | -4,099.00 |
| Dec 31, 2017 | 6,941.00 |